Eli Lilly’s Oral GLP-1 Approved, SpaceX Confidentially Files for IPO, Potential Activist Targets 4/1/26
CNBC's Money Movers covers the FDA approval of Eli Lilly's oral weight-loss drug, reports of SpaceX's confidential IPO filing, and potential activist investor targets identified by Barclays.